# Trazodone Dose Tolerance and APAP Adherence

> **NCT02945644** · PHASE1 · SUSPENDED · sponsor: **Louis Stokes VA Medical Center** · enrollment: 45 (estimated)

## Conditions studied

- Sleep Apnea, Obstructive

## Interventions

- **DRUG:** Trazodone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02945644
- **Lead sponsor:** Louis Stokes VA Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2017-02-13
- **Primary completion:** 2020-09
- **Final completion:** 2020-12
- **Target enrollment:** 45 (ESTIMATED)
- **Why stopped:** COVID19 pandemic
- **Last updated:** 2020-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02945644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02945644, "Trazodone Dose Tolerance and APAP Adherence". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02945644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*